1 Ophthalmic Medicine Market Overview

• 1.1 Product Overview and Scope of Ophthalmic Medicine
• 1.2 Ophthalmic Medicine Segment by Type
  • 1.2.1 Global Ophthalmic Medicine Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Eye Drops
  • 1.2.3 Eye Ointment
  • 1.2.4 Gelling Agent
  • 1.2.5 Tablet
  • 1.2.6 Injection
• 1.3 Ophthalmic Medicine Segment by Application
  • 1.3.1 Ophthalmic Medicine Sales Comparison by Application: (2021-2027)
  • 1.3.2 Anti-fatigue and Dryness
  • 1.3.3 Cataract
  • 1.3.4 Anti-infective
• 1.4 Global Ophthalmic Medicine Market Size Estimates and Forecasts
  • 1.4.1 Global Ophthalmic Medicine Revenue 2016-2027
  • 1.4.2 Global Ophthalmic Medicine Sales 2016-2027
  • 1.4.3 Ophthalmic Medicine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Ophthalmic Medicine Market Competition by Manufacturers

• 2.1 Global Ophthalmic Medicine Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Ophthalmic Medicine Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Ophthalmic Medicine Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Ophthalmic Medicine Manufacturing Sites, Area Served, Product Type
• 2.5 Ophthalmic Medicine Market Competitive Situation and Trends
  • 2.5.1 Ophthalmic Medicine Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Ophthalmic Medicine Players Market Share by Revenue
  • 2.5.3 Global Ophthalmic Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Ophthalmic Medicine Retrospective Market Scenario by Region

• 3.1 Global Ophthalmic Medicine Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Ophthalmic Medicine Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Ophthalmic Medicine Market Facts & Figures by Country
  • 3.3.1 North America Ophthalmic Medicine Sales by Country
  • 3.3.2 North America Ophthalmic Medicine Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Ophthalmic Medicine Market Facts & Figures by Country
  • 3.4.1 Europe Ophthalmic Medicine Sales by Country
  • 3.4.2 Europe Ophthalmic Medicine Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Ophthalmic Medicine Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Ophthalmic Medicine Sales by Region
  • 3.5.2 Asia Pacific Ophthalmic Medicine Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Ophthalmic Medicine Market Facts & Figures by Country
  • 3.6.1 Latin America Ophthalmic Medicine Sales by Country
  • 3.6.2 Latin America Ophthalmic Medicine Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Ophthalmic Medicine Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Ophthalmic Medicine Sales by Country
  • 3.7.2 Middle East and Africa Ophthalmic Medicine Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Ophthalmic Medicine Historic Market Analysis by Type

• 4.1 Global Ophthalmic Medicine Sales Market Share by Type (2016-2021)
• 4.2 Global Ophthalmic Medicine Revenue Market Share by Type (2016-2021)
• 4.3 Global Ophthalmic Medicine Price by Type (2016-2021)

5 Global Ophthalmic Medicine Historic Market Analysis by Application

• 5.1 Global Ophthalmic Medicine Sales Market Share by Application (2016-2021)
• 5.2 Global Ophthalmic Medicine Revenue Market Share by Application (2016-2021)
• 5.3 Global Ophthalmic Medicine Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Novaliq
  • 6.1.1 Novaliq Corporation Information
  • 6.1.2 Novaliq Description and Business Overview
  • 6.1.3 Novaliq Ophthalmic Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Novaliq Product Portfolio
  • 6.1.5 Novaliq Recent Developments/Updates
• 6.2 Shenyang Xingqi Pharmaceutical Co.,Ltd.
  • 6.2.1 Shenyang Xingqi Pharmaceutical Co.,Ltd. Corporation Information
  • 6.2.2 Shenyang Xingqi Pharmaceutical Co.,Ltd. Description and Business Overview
  • 6.2.3 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Shenyang Xingqi Pharmaceutical Co.,Ltd. Product Portfolio
  • 6.2.5 Shenyang Xingqi Pharmaceutical Co.,Ltd. Recent Developments/Updates
• 6.3 Zhejiang Shapuaisi Pharmaceutical
  • 6.3.1 Zhejiang Shapuaisi Pharmaceutical Corporation Information
  • 6.3.2 Zhejiang Shapuaisi Pharmaceutical Description and Business Overview
  • 6.3.3 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Zhejiang Shapuaisi Pharmaceutical Product Portfolio
  • 6.3.5 Zhejiang Shapuaisi Pharmaceutical Recent Developments/Updates
• 6.4 Chengdu Kanghong Pharmaceutical Group
  • 6.4.1 Chengdu Kanghong Pharmaceutical Group Corporation Information
  • 6.4.2 Chengdu Kanghong Pharmaceutical Group Description and Business Overview
  • 6.4.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Chengdu Kanghong Pharmaceutical Group Product Portfolio
  • 6.4.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
• 6.5 Santen Pharmaceutica
  • 6.5.1 Santen Pharmaceutica Corporation Information
  • 6.5.2 Santen Pharmaceutica Description and Business Overview
  • 6.5.3 Santen Pharmaceutica Ophthalmic Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Santen Pharmaceutica Product Portfolio
  • 6.5.5 Santen Pharmaceutica Recent Developments/Updates
• 6.6 Bausch Health
  • 6.6.1 Bausch Health Corporation Information
  • 6.6.2 Bausch Health Description and Business Overview
  • 6.6.3 Bausch Health Ophthalmic Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Bausch Health Product Portfolio
  • 6.6.5 Bausch Health Recent Developments/Updates
• 6.7 Alcon NV
  • 6.6.1 Alcon NV Corporation Information
  • 6.6.2 Alcon NV Description and Business Overview
  • 6.6.3 Alcon NV Ophthalmic Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Alcon NV Product Portfolio
  • 6.7.5 Alcon NV Recent Developments/Updates
• 6.8 Mentholatum
  • 6.8.1 Mentholatum Corporation Information
  • 6.8.2 Mentholatum Description and Business Overview
  • 6.8.3 Mentholatum Ophthalmic Medicine Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Mentholatum Product Portfolio
  • 6.8.5 Mentholatum Recent Developments/Updates

7 Ophthalmic Medicine Manufacturing Cost Analysis

• 7.1 Ophthalmic Medicine Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Ophthalmic Medicine
• 7.4 Ophthalmic Medicine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Ophthalmic Medicine Distributors List
• 8.3 Ophthalmic Medicine Customers

9 Ophthalmic Medicine Market Dynamics

• 9.1 Ophthalmic Medicine Industry Trends
• 9.2 Ophthalmic Medicine Growth Drivers
• 9.3 Ophthalmic Medicine Market Challenges
• 9.4 Ophthalmic Medicine Market Restraints

10 Global Market Forecast

• 10.1 Ophthalmic Medicine Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Ophthalmic Medicine by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Ophthalmic Medicine by Type (2022-2027)
• 10.2 Ophthalmic Medicine Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Ophthalmic Medicine by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Ophthalmic Medicine by Application (2022-2027)
• 10.3 Ophthalmic Medicine Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Ophthalmic Medicine by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Ophthalmic Medicine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Eye Drops
Eye Ointment
Gelling Agent
Tablet
Injection

Segment by Application
Anti-fatigue and Dryness
Cataract
Anti-infective

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Novaliq
Shenyang Xingqi Pharmaceutical Co.,Ltd.
Zhejiang Shapuaisi Pharmaceutical
Chengdu Kanghong Pharmaceutical Group
Santen Pharmaceutica
Bausch Health
Alcon NV
Mentholatum